[{"Assets_0_Q3_USD":734976000.0,"CIK":"1628171","CommonStockSharesConverted_0_Q3_shares":73654880.0,"CommonStockSharesOutstanding_0_Q3_shares":73654880.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.72,"EarningsPerShareBasic_3_Q3_USD":-1.85,"Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-107915000.0,"NetIncomeLossConverted_1_Q3_USD":-52940000.0,"NetIncomeLossConverted_3_Q3_USD":-134415000.0,"OfficialName":"Revolution Medicines Inc. Common Stock","RevenuesConverted_1_Q3_USD":1101000.0,"RevenuesConverted_3_Q3_USD":19930000.0,"SP500":"nan","Sector":"Consumer Durables","StockholdersEquity_0_Q3_USD":638204000.0,"Ticker":"RVMD","filed":"20211110","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"REVOLUTION MEDICINES, INC.","period":"20210930","qtrs":"0","uom":"USD"}]